AURA
Aura Biosciences, Inc.
-0.09 (-1.34%)6.64USD265K成交股數689M市值–本益比(近四季)100.4股價營收比+37.5%營收年增(近四季)2026-11-12下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 78.3M |
| 近 180 天 淨額 | −78.3M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-01 | 09-01 | Abu-Absi Susan | Chief Operating Officer | A 獲配股票 | 135K | – | – | 135K | SEC |
| 2026-09-01 | 09-01 | Elazzouzi Amy | SVP, Finance & PAO | A 獲配股票 | 23.5K | – | – | 144K | SEC |
| 2026-09-01 | 09-01 | Hopkins Janet Jill | Chief Medical Officer | A 獲配股票 | 58.9K | – | – | 380K | SEC |
| 2026-09-01 | 09-01 | Kratz Erica | Chief Reg. & Quality Officer | A 獲配股票 | 101K | – | – | 101K | SEC |
| 2026-09-01 | 09-01 | Person Julie | Chief People Officer | A 獲配股票 | 108K | – | – | 108K | SEC |
| 2026-07-07 | 07-08 | Bender Jeremy | Director | A 獲配股票 | 30.0K | – | – | 30.0K | SEC |
| 2026-07-01 | 07-01 | Kilroy Conor | See Remarks | A 獲配股票 | 14.9K | – | – | 233K | SEC |
| 2026-06-16 | 06-16 | Gibney Anthony S | See Remarks | S 公開市場賣出 | 12.8K | 6.42 | 82K | 265K | SEC |
| 2026-06-11 | 06-15 | Mattessich Antony C. | Director | A 獲配股票 | 15.0K | – | – | 38.5K | SEC |
| 2026-06-11 | 06-15 | Johnson David Michael | Director | A 獲配股票 | 15.0K | – | – | 194K | SEC |
| 2026-06-11 | 06-15 | Srivastava Sapna | Director | A 獲配股票 | 15.0K | – | – | 38.5K | SEC |
| 2026-06-11 | 06-15 | Bitetti Teresa Marie | Director | A 獲配股票 | 15.0K | – | – | 36.0K | SEC |
| 2026-05-19 | 05-19 | Holles Natalie C. | See Remarks | A 獲配股票 | 600K | – | – | 600K | SEC |
| 2026-05-19 | 05-19 | Holles Natalie C. | See Remarks | A 獲配股票 | 554K | – | – | 1.2M | SEC |
| 2026-05-07 | 05-11 | Matrix Capital Management Company, LP | TenPercentOwner | S 公開市場賣出 | 6.9M | 5.64 | 39.0M | 0 | SEC |
| 2026-05-07 | 05-11 | GOEL DAVID E. | TenPercentOwner | S 公開市場賣出 | 6.9M | 5.64 | 39.0M | 0 | SEC |
| 2026-04-16 | 04-16 | Kilroy Conor | See Remarks | S 公開市場賣出 | 11.7K | 7.02 | 82K | 218K | SEC |
| 2026-03-02 | 03-03 | Elazzouzi Amy | Senior Vice President, Finance | A 獲配股票 | 44.5K | – | – | 120K | SEC |
| 2026-03-02 | 03-03 | Hopkins Janet Jill | Chief Medical Officer | A 獲配股票 | 89.1K | – | – | 321K | SEC |
| 2026-03-02 | 03-03 | Plavsic Mark | Chief Technology Officer | A 獲配股票 | 62.3K | – | – | 244K | SEC |
| 2026-03-02 | 03-03 | de los Pinos Elisabet | See Remarks | A 獲配股票 | 166K | – | – | 576K | SEC |
| 2026-03-02 | 03-03 | Gibney Anthony S | See Remarks | A 獲配股票 | 71.2K | – | – | 278K | SEC |
| 2026-03-02 | 03-03 | Kilroy Conor | See Remarks | A 獲配股票 | 62.3K | – | – | 230K | SEC |
| 2026-02-17 | 02-17 | de los Pinos Elisabet | See Remarks | S 公開市場賣出 | 47.6K | 5.06 | 241K | 410K | SEC |
| 2026-02-17 | 02-17 | Elazzouzi Amy | Senior Vice President, Finance | S 公開市場賣出 | 8.5K | 5.06 | 43K | 75.5K | SEC |
| 2026-02-17 | 02-17 | Hopkins Janet Jill | Chief Medical Officer | S 公開市場賣出 | 20.4K | 5.06 | 103K | 232K | SEC |
| 2026-02-17 | 02-17 | Plavsic Mark | Chief Technology Officer | S 公開市場賣出 | 15.9K | 5.05 | 80K | 181K | SEC |
| 2026-02-17 | 02-17 | Kilroy Conor | See Remarks | S 公開市場賣出 | 12.1K | 5.05 | 61K | 167K | SEC |
| 2026-01-20 | 01-20 | de los Pinos Elisabet | See Remarks | S 公開市場賣出 | 16.9K | 4.86 | 82K | 457K | SEC |
| 2026-01-20 | 01-20 | Elazzouzi Amy | Senior Vice President, Finance | S 公開市場賣出 | 1.6K | 4.86 | 8K | 84.1K | SEC |
| 2025-11-17 | 11-17 | Hopkins Janet Jill | Chief Medical Officer | S 公開市場賣出 | 17.1K | 5.42 | 93K | 253K | SEC |
| 2025-10-29 | 10-29 | de los Pinos Elisabet | See Remarks | S 公開市場賣出 | 9.0K | 6.35 | 57K | 474K | SEC |
| 2025-10-29 | 10-29 | Elazzouzi Amy | Senior Vice President, Finance | S 公開市場賣出 | 896 | 6.35 | 6K | 85.7K | SEC |
| 2025-10-16 | 10-16 | Plavsic Mark | Chief Technology Officer | S 公開市場賣出 | 12.2K | 6.35 | 77K | 197K | SEC |
| 2025-08-18 | 08-18 | Elazzouzi Amy | Senior Vice President, Finance | M 選擇權執行 | 2.6K | 5.07 | 13K | 83.9K | SEC |
| 2025-08-18 | 08-18 | Elazzouzi Amy | Senior Vice President, Finance | M 選擇權執行 | 1.1K | 5.48 | 6K | 85.0K | SEC |
| 2025-08-18 | 08-18 | Elazzouzi Amy | Senior Vice President, Finance | M 選擇權執行 | 547 | 5.48 | 3K | 85.6K | SEC |
| 2025-08-18 | 08-18 | Elazzouzi Amy | Senior Vice President, Finance | M 選擇權執行 | 547 | 5.21 | 3K | 86.1K | SEC |
| 2025-08-18 | 08-18 | Elazzouzi Amy | Senior Vice President, Finance | M 選擇權執行 | 4.7K | 2.74 | 13K | 90.9K | SEC |
| 2025-08-18 | 08-18 | Elazzouzi Amy | Senior Vice President, Finance | M 選擇權執行 | 1.1K | 3.16 | 3K | 92.0K | SEC |
| 2025-08-18 | 08-18 | Elazzouzi Amy | Senior Vice President, Finance | M 選擇權執行 | 2.3K | 4.25 | 10K | 94.3K | SEC |
| 2025-08-18 | 08-18 | Elazzouzi Amy | Senior Vice President, Finance | S 公開市場賣出 | 7.7K | 6.70 | 52K | 86.6K | SEC |
| 2025-06-17 | 06-18 | Mattessich Antony C. | Director | A 獲配股票 | 13.0K | – | – | 23.5K | SEC |
| 2025-06-17 | 06-18 | Johnson David Michael | Director | A 獲配股票 | 13.0K | – | – | 179K | SEC |
| 2025-06-17 | 06-18 | Srivastava Sapna | Director | A 獲配股票 | 13.0K | – | – | 23.5K | SEC |
| 2025-06-02 | 06-04 | de los Pinos Elisabet | See Remarks | M 選擇權執行 | 10.9K | 5.07 | 56K | 493K | SEC |
| 2025-06-02 | 06-04 | de los Pinos Elisabet | See Remarks | F 繳稅扣股 | 9.9K | 6.16 | 61K | 483K | SEC |
| 2025-06-02 | 06-04 | Gibney Anthony S | See Remarks | A 獲配股票 | 150K | – | – | 207K | SEC |
| 2025-05-16 | 05-20 | Gibney Anthony S | See Remarks | P 公開市場買進 | 50.0K | 4.90 | 245K | 58.5K | SEC |
| 2025-05-16 | 05-20 | Gibney Anthony S | See Remarks | S 公開市場賣出 | 1.5K | 5.15 | 8K | 56.9K | SEC |
| 2025-05-16 | 05-20 | Johnson David Michael | Director | P 公開市場買進 | 20.0K | 4.90 | 98K | 166K | SEC |
| 2025-04-16 | 04-16 | Kilroy Conor | See Remarks | S 公開市場賣出 | 7.2K | 5.49 | 39K | 179K | SEC |
| 2025-04-16 | 04-16 | Elazzouzi Amy | Senior Vice President, Finance | S 公開市場賣出 | 897 | 5.49 | 5K | 81.4K | SEC |
| 2025-03-31 | 04-02 | Bitetti Teresa Marie | Director | A 獲配股票 | 21.0K | – | – | 21.0K | SEC |
| 2025-02-18 | 02-18 | de los Pinos Elisabet | See Remarks | S 公開市場賣出 | 20.2K | 7.75 | 157K | 482K | SEC |
| 2025-02-18 | 02-18 | Hopkins Janet Jill | Chief Medical Officer | S 公開市場賣出 | 2.5K | 7.75 | 20K | 270K | SEC |
| 2025-02-18 | 02-18 | Elazzouzi Amy | Senior Vice President, Finance | S 公開市場賣出 | 1.4K | 7.75 | 11K | 82.3K | SEC |
| 2025-02-18 | 02-18 | Plavsic Mark | Chief Technology Officer | S 公開市場賣出 | 2.2K | 7.75 | 17K | 209K | SEC |
| 2025-02-03 | 02-04 | Elazzouzi Amy | Senior Vice President, Finance | A 獲配股票 | 45.2K | – | – | 83.7K | SEC |
| 2025-02-03 | 02-04 | Kilroy Conor | See Remarks | A 獲配股票 | 90.5K | – | – | 186K | SEC |
| 2025-02-03 | 02-04 | Hopkins Janet Jill | Chief Medical Officer | A 獲配股票 | 121K | – | – | 272K | SEC |
| 2025-02-03 | 02-04 | Plavsic Mark | Chief Technology Officer | A 獲配股票 | 90.5K | – | – | 212K | SEC |
| 2025-02-03 | 02-04 | de los Pinos Elisabet | See Remarks | A 獲配股票 | 194K | – | – | 503K | SEC |
| 2025-01-21 | 01-21 | Elazzouzi Amy | Vice President, Finance | S 公開市場賣出 | 1.0K | 7.67 | 8K | 38.4K | SEC |
| 2025-01-21 | 01-21 | de los Pinos Elisabet | See Remarks | S 公開市場賣出 | 16.0K | 7.67 | 122K | 305K | SEC |
| 2024-11-18 | 11-18 | Hopkins Janet Jill | Chief Medical Officer | S 公開市場賣出 | 11.8K | 9.36 | 111K | 152K | SEC |
| 2024-10-29 | 10-29 | Elazzouzi Amy | Vice President, Finance | S 公開市場賣出 | 553 | 10.74 | 6K | 39.4K | SEC |
| 2024-10-29 | 10-29 | de los Pinos Elisabet | See Remarks | S 公開市場賣出 | 9.2K | 10.74 | 99K | 321K | SEC |
| 2024-10-18 | 10-21 | Feder Julie B | Chief Financial Officer | M 選擇權執行 | 17.5K | 2.74 | 48K | 152K | SEC |
| 2024-10-18 | 10-21 | Feder Julie B | Chief Financial Officer | M 選擇權執行 | 2.6K | 4.25 | 11K | 154K | SEC |
| 2024-10-18 | 10-21 | Feder Julie B | Chief Financial Officer | M 選擇權執行 | 5.0K | 5.48 | 27K | 159K | SEC |
| 2024-10-18 | 10-21 | Feder Julie B | Chief Financial Officer | S 公開市場賣出(10b5-1) | 25.1K | 12.03 | 302K | 134K | SEC |
| 2024-10-18 | 10-18 | de los Pinos Elisabet | See Remarks | M 選擇權執行 | 25.0K | 2.74 | 68K | 355K | SEC |
| 2024-10-18 | 10-18 | de los Pinos Elisabet | See Remarks | S 公開市場賣出(10b5-1) | 25.0K | 12.04 | 301K | 330K | SEC |
| 2024-10-16 | 10-16 | Plavsic Mark | Chief Technology Officer | S 公開市場賣出 | 7.4K | 9.85 | 73K | 121K | SEC |
| 2024-09-27 | 10-01 | de los Pinos Elisabet | See Remarks | M 選擇權執行 | 5.5K | 5.76 | 32K | 330K | SEC |
| 2024-06-20 | 06-24 | Johnson David Michael | Director | A 獲配股票 | 10.5K | – | – | 146K | SEC |
| 2024-06-20 | 06-24 | Srivastava Sapna | Director | A 獲配股票 | 10.5K | – | – | 10.5K | SEC |
| 2024-06-20 | 06-24 | Mattessich Antony C. | Director | A 獲配股票 | 10.5K | – | – | 10.5K | SEC |
| 2024-04-02 | 04-04 | Kilroy Conor | General Counsel and Secretary | A 獲配股票 | 96.0K | – | – | 96.0K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| TCG Crossover Management, LLC | 9.5M | 67.7M | 新進 | 新進 |
| MONTANOVA CAPITAL, LLC | 7.2M | 51.2M | +2.8M (+65%) | 加碼 |
| Frazier Life Sciences Management, L.P. | 7.1M | 50.4M | +2.0M (+39%) | 加碼 |
| Nantahala Capital Management, LLC | 5.9M | 41.9M | +3.8M (+179%) | 加碼 |
| Long Focus Capital Management, LLC | 5.1M | 36.3M | +500K (+11%) | 加碼 |
| BlackRock, Inc. | 4.7M | 33.4M | +1.1M (+31%) | 加碼 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.6M | 32.9M | −241K (-5%) | 減碼 |
| Caligan Partners LP | 4.3M | 30.5M | +4.1M (+1770%) | 加碼 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.1M | 29.1M | +1.9M (+83%) | 加碼 |
| FCPM III SERVICES B.V. | 4.1M | 28.8M | 新進 | 新進 |
| ORBIMED ADVISORS LLC | 3.3M | 23.7M | 新進 | 新進 |
| Medicxi Ventures Management (Jersey) Ltd | 3.0M | 21.6M | 不變 | 持平 |
| Jupiter Topco LLC | 2.5M | 17.8M | 新進 | 新進 |
| RA CAPITAL MANAGEMENT, L.P. | 2.5M | 17.8M | 新進 | 新進 |
| Balyasny Asset Management L.P. | 2.4M | 16.7M | +1.8M (+322%) | 加碼 |
| FRANKLIN RESOURCES INC | 2.1M | 14.7M | 不變 | 持平 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8M | 12.5M | +444K (+34%) | 加碼 |
| EcoR1 Capital, LLC | 1.7M | 11.8M | 新進 | 新進 |
| Redmile Group, LLC | 1.7M | 11.8M | 新進 | 新進 |
| Trails Edge Capital Partners, LP | 1.4M | 10.2M | 新進 | 新進 |
| Foresite Capital Management VI LLC | 1.3M | 9.5M | 新進 | 新進 |
| STATE STREET CORP | 1.2M | 8.7M | +258K (+27%) | 加碼 |
| Woodline Partners LP | 1.2M | 8.6M | 新進 | 新進 |
| Bellevue Group AG | 1.2M | 8.3M | 新進 | 新進 |
| Vivo Capital, LLC | 1.2M | 8.3M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 146 +20 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 37 / 17 / 56 / 26 |
| 機構合計持股 · 佔流通股 | 98.3M · 94.8% |
| 合計季末市值 | 696M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 6.2M |
|---|---|
| 與上期比 | +0.7% |
| 佔流通股數 | 5.98% |
| 日均成交量 | 972K |
| 回補天數 | 6.4 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 6.2M | +0.7% | 5.98% | 972K | 6.4 |
| 2026-08-14 | 6.2M | -3.1% | 5.94% | 622K | 9.9 |
| 2026-07-31 | 6.4M | +13.4% | 6.13% | 344K | 18.5 |
| 2026-07-15 | 5.6M | -19.1% | 5.41% | 693K | 8.1 |
| 2026-06-30 | 6.9M | +28.7% | 6.68% | 742K | 9.3 |
| 2026-06-15 | 5.4M | +43.1% | 5.19% | 522K | 10.3 |
| 2026-05-29 | 3.8M | +19.2% | 3.63% | 496K | 7.6 |
| 2026-05-15 | 3.2M | +44.0% | 3.04% | 1.1M | 2.8 |
| 2026-04-30 | 2.2M | +8.9% | 2.11% | 275K | 8.0 |
| 2026-04-15 | 2.0M | -23.0% | 1.94% | 328K | 6.1 |
| 2026-03-31 | 2.6M | +4.3% | 2.52% | 295K | 8.9 |
| 2026-03-13 | 2.5M | +11.5% | 2.42% | 283K | 8.9 |
| 2026-02-27 | 2.2M | -22.1% | 2.17% | 208K | 10.8 |
| 2026-02-13 | 2.9M | -8.8% | 2.78% | 188K | 15.4 |
| 2026-01-30 | 3.2M | -0.9% | 3.05% | 181K | 17.5 |
| 2026-01-15 | 3.2M | +0.6% | 3.08% | 179K | 17.9 |
| 2025-12-31 | 3.2M | +3.7% | 3.06% | 205K | 15.5 |
| 2025-12-15 | 3.1M | -5.3% | 2.95% | 149K | 20.5 |
| 2025-11-28 | 3.2M | +10.6% | 3.12% | 243K | 13.3 |
| 2025-11-14 | 2.9M | -0.0% | 2.82% | 200K | 14.6 |
| 2025-10-31 | 2.9M | -7.0% | 2.82% | 303K | 9.7 |
| 2025-10-15 | 3.1M | +0.3% | 3.03% | 264K | 11.9 |
| 2025-09-30 | 3.1M | +7.3% | 3.02% | 365K | 8.6 |
| 2025-09-15 | 2.9M | +4.6% | 2.82% | 172K | 17.0 |
| 2025-08-29 | 2.8M | +1.9% | 2.69% | 145K | 19.3 |
| 2025-08-15 | 2.7M | -0.8% | 2.64% | 146K | 18.8 |